Search bioRxiv⌕ Search

Biology subjects

Klimke, S.

Publications and source records attributed to Klimke, S..

3 recordsLinked to original sources

Monitoring intracellular antibiotic concentrations in real-time using allosteric biosensors

Antibiotic treatment can fail due to insufficient drug availability at the site of infection or limited accumulation within bacterial pathogens. However, it is poorly understood how antibiotics penetrate infected tissues and complex bacterial aggregates, limiting insights into the mechanisms of treatment failure. Here, we present genetically-encoded allosteric biosensors for two antibiotic classes, trimethoprim and tetracycline, which enable real-time monitoring of antibiotic concentrations inside bacterial cells. The biosensors consist of circularly permuted EGFP linked to the sensory domains DHFR or TetR. To extend this approach to low oxygen environments, we engineered an oxygen-independent trimethoprim biosensor by fusing DHFR to a circularly permuted version of the fluorogenic protein FAST. Using these biosensors, we monitored the antibiotic exposure dynamics of intracellular Salmonella enterica during macrophage infection at the single-cell level, and antibiotic penetration into anaerobic regions of Vibrio cholerae biofilms, as well as antibiotic availability in microoxic conditions in a human bladder tissue model infected with uropathogenic Escherichia coli. These fluorescent biosensors have the potential to be broadly applied for determining antibiotic distributions at infection sites with high spatial and temporal resolution.

microbiology↗

Perfusable 3D human urothelial model for real-time analysis of bacterial infection dynamics and therapeutic interventions

Urinary tract infections (UTIs) remain a major health burden, yet mechanistic studies are limited by the lack of experimental models that enable high spatiotemporal resolution tracking of infection dynamics, while recapitulating the stratified architecture of the bladder epithelium, urine tolerance and fluid dynamics. Here, we present a modular microphysiological platform integrating a fully stratified, urine-tolerant human urothelium cultured on standard transwell inserts within a custom-designed perfusion device compatible with live imaging. Urine flow enables real-time, high-resolution imaging of uropathogenic Escherichia coli (UPEC) infections under physiologically relevant conditions, including clearance of planktonic bacteria and nutrients replenishment, while retaining tissue-associated populations. This system revealed UPEC attachment via the type 1 fimbrial adhesin FimH and its inhibition by D-mannose treatment. Moreover, the platform captured L-form formation upon treatment with the frontline antibiotic fosfomycin and regrowth of walled bacteria following drug withdrawal. The platform further uncovered strain-specific lysis through bacteriophages in contrast to the activity of broad-spectrum antibiotics. In summary, this system constitutes a scalable platform with high predictive power for studying UTI pathogenesis and preclinical therapeutic testing.

bioengineering↗

Genome-scale CRISPRi profiling reveals metabolic vulnerabilities of uropathogenic Escherichia coli in human urine

Urinary tract infections (UTIs) are among the most common infectious diseases, causing over 400 million cases and 260,000 deaths annually. Women are disproportionately affected, with [~]50% experiencing at least one UTI during their lifetime and 20-30% suffering from recurrent infections. Uropathogenic Escherichia coli (UPEC), which accounts for [~]75% of cases, employs diverse virulence factors to persist and evade host immunity. Rising antibiotic resistance, driven by widespread antimicrobial misuse, is eroding treatment efficacy and highlights the urgent need for alternative therapeutic strategies. To uncover novel vulnerabilities under physiologically relevant conditions, we constructed a genome-wide CRISPR interference (CRISPRi) library in the UPEC reference strain E. coli CFT073 and systematically profiled gene fitness in rich media versus human urine. The screen revealed multiple pathways that are conditionally essential for UPEC growth in urine, including iron uptake, envelope maintenance, and the biosynthesis of arginine, methionine, and branched-chain amino acids. Notably, we identified acetolactate synthase (ALS) II as the sole active isoform supporting branched-chain amino acid synthesis in urine. Functional validation further demonstrated its druggability: introducing a re-sensitizing mutation overcame the proteins intrinsic resistance to the ALS-targeting herbicide sulfometuron methyl, restoring sensitivity. These findings establish ALS II as a promising therapeutic target against UPEC.

microbiology↗